We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lupin Warned by FDA for Repeat Violations at Mandideep Plant
Lupin Warned by FDA for Repeat Violations at Mandideep Plant
The FDA issued a warning letter to Lupin Pharmaceuticals over repeated failures at its Mandideep site near Bhopal in central India, including inadequate out-of-specification investigations.